✨ Medicines Distribution Consent




NEW ZEALAND GAZETTE, No. 44

19 APRIL 2012

Product: Decozol
Active Ingredient: Miconazole 2%w/w
Dosage Form: Oral gel
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Hoe Pharmaceuticals Sdn Bhd, Selangor, Malaysia

Product: GN-Oxaliplatin
Active Ingredient: Oxaliplatin 50mg
Dosage Form: Powder for injection
New Zealand Sponsor: Saltarelo Holdings Limited
Manufacturer: Onco Therapies Limited, Bangalore Karnataka, India

Product: GN-Oxaliplatin
Active Ingredient: Oxaliplatin 100mg
Dosage Form: Powder for injection
New Zealand Sponsor: Saltarelo Holdings Limited
Manufacturer: Onco Therapies Limited, Bangalore Karnataka, India

Product: GN-Oxaliplatin
Active Ingredient: Oxaliplatin 5mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Saltarelo Holdings Limited
Manufacturer: Onco Therapies Limited, Bangalore Karnataka, India

Product: Juvederm VOLUMA with Lidocaine
Active Ingredients: Lidocaine hydrochloride 3mg/mL
Sodium hyaluronate 20mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan France, Pringy, France

Product: Oxaliplatin-PF
Active Ingredient: Oxaliplatin 50mg
Dosage Form: Powder for injection
New Zealand Sponsor: Saltarelo Holdings Limited
Manufacturer: Onco Therapies Limited, Bangalore Karnataka, India

Product: Oxaliplatin-PF
Active Ingredient: Oxaliplatin 100mg
Dosage Form: Powder for injection
New Zealand Sponsor: Saltarelo Holdings Limited
Manufacturer: Onco Therapies Limited, Bangalore Karnataka, India

Product: Oxaliplatin-PF
Active Ingredient: Oxaliplatin 5mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Saltarelo Holdings Limited
Manufacturer: Onco Therapies Limited, Bangalore Karnataka, India

Dated this 11th day of April 2012.

DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go2281

Renewal of Provisional Consent to the Distribution of Medicines

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:

Schedule

Product: Gutron
Active Ingredient: Midodrine hydrochloride 2.5mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturers: Nycomed GmbH, Oranienburg, Germany
Nycomed Danmark ApS, Hvidovre, Denmark

Note: This renewed consent is valid for two years from 30 April 2012.



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2012, No 44





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
11 April 2012
Medicines, Distribution, Consent, New Zealand
  • DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health

πŸ₯ Renewal of Provisional Consent to the Distribution of Medicines

πŸ₯ Health & Social Welfare
Medicines, Provisional Consent, Renewal, New Zealand